Eric Christenson

Eric Christenson has a diverse work experience in the field of protein synthesis, assay testing, engineering, and antibody development. Eric'smost recent role was as the Associate Director of Protein Synthesis & Assay Testing at Seed Therapeutics since June 2023. Prior to that, they worked as a Principal Scientist II - Protein Sciences at the same company from November 2022 to June 2023. Before joining Seed Therapeutics, Eric worked as a Scientist II - Protein Engineering & Antibody Development at OriGene Technologies, Inc. from April 2021 to November 2022. Eric also worked as a Scientist at Kelly Government Solutions, National Institutes of Health from February 2019 to April 2021. Eric's career started as a Postdoctoral Fellow at the National Institutes of Health from February 2013 to February 2019. Prior to that, they served as a W. M. Keck Postdoctoral Fellow in Molecular Medicine and a Doctoral Candidate at Washington University School of Medicine from July 2011 to October 2012 and August 2003 to July 2011, respectively. Eric began their professional journey as a Research Technician at West Virginia University from June 2002 to August 2003.

Eric Christenson received their Bachelor of Science (B.S.) degree in Biology, General from West Virginia University, where they studied from 1998 to 2002. Eric then pursued further education and completed a Doctor of Philosophy (Ph.D.) degree in Biochemistry at the Washington University School of Medicine in St. Louis. Eric'sdoctoral studies took place from 2003 to 2011.